Simultaneous transplantation of hematopoietic stem cells and a vascularized composite allograft leads to tolerance

BACKGROUND: We have previously demonstrated that tolerance to a vascularized composite allograft (VCA) can be achieved after the establishment of mixed chimerism. We test the hypothesis that tolerance to a VCA in our dog leukocyte antigen-matched canine model is not dependent on the previous establishment of mixed chimerism and can be induced coincident with hematopoietic cell transplantation (HCT).

METHODS: Eight dog leukocyte antigen-matched, minor antigen mismatched dogs received 200 cGy of radiation and a VCA transplant. Four dogs received donor bone marrow at the time of VCA transplantation (group 1), whereas a second group of four dogs did not (group 2). All recipients received a limited course of postgrafting immunosuppression. All dogs that received HCT and VCA were given donor, third-party, and autologous skin grafts.

RESULTS: All group 1 recipients were tolerant to their VCA (>62 weeks). Three of the four dogs in group 2 rejected their VCA transplants after the cessation of immunosuppression. Biopsies obtained from the muscle and skin of VCA from group 1 showed few infiltrating cells compared with extensive infiltrates in biopsies of VCA from group 2. Compared with autologous skin and muscle, elevated levels of CD3+ FoxP3+ T-regulatory cells were found in the skin and muscle obtained from the VCA of HCT recipients. All group 1 animals were tolerant to their donor skin graft and promptly rejected the third-party skin grafts.

CONCLUSION: These data demonstrated that donor-specific tolerance to all components of the VCA can be established through simultaneous nonmyeloablative allogeneic HCT and VCA transplantation protocol.

Medienart:

E-Artikel

Erscheinungsjahr:

2014

Erschienen:

2014

Enthalten in:

Zur Gesamtaufnahme - volume:98

Enthalten in:

Transplantation - 98(2014), 2 vom: 27. Juli, Seite 131-8

Sprache:

Englisch

Beteiligte Personen:

Mathes, David W [VerfasserIn]
Chang, Jeff [VerfasserIn]
Hwang, Billanna [VerfasserIn]
Graves, Scott S [VerfasserIn]
Storer, Barry E [VerfasserIn]
Butts-Miwongtum, Tiffany [VerfasserIn]
Sale, George E [VerfasserIn]
Storb, Rainer [VerfasserIn]

Links:

Volltext

Themen:

Biomarkers
CD3 Complex
Cytokines
Forkhead Transcription Factors
Histocompatibility Antigens
Immunosuppressive Agents
Journal Article
Myeloablative Agonists
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

Anmerkungen:

Date Completed 08.09.2014

Date Revised 21.10.2021

published: Print

Citation Status MEDLINE

doi:

10.1097/TP.0000000000000204

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM23908280X